Related Experiment Videos
Prognostic factors in bladder and bladder-prostate rhabdomyosarcoma
M P La Quaglia1, F Ghavimi, H Herr
1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10075.
Journal of Pediatric Surgery
|October 1, 1990
Summary
Complete surgical resection is crucial for survival in pediatric bladder rhabdomyosarcoma. Achieving negative microscopic margins through cystectomy significantly improves outcomes for these rare urinary tract cancers.
Area of Science:
- Pediatric Oncology
- Surgical Oncology
- Urologic Oncology
Background:
- Rhabdomyosarcoma of the urinary bladder is a rare pediatric malignancy.
- Identifying prognostic factors, particularly surgical, is essential for optimizing treatment strategies.
- Previous studies have not fully elucidated the role of surgical resection in fatal outcomes.
Purpose of the Study:
- To investigate surgical factors predicting fatal outcomes in patients with bladder rhabdomyosarcoma.
- To analyze the impact of complete surgical resection on survival rates.
- To evaluate the effectiveness of different surgical approaches and timing in conjunction with multimodal therapy.
Main Methods:
- Retrospective analysis of 25 patients diagnosed with bladder rhabdomyosarcoma between 1970 and 1985.
- Data included patient demographics, clinical staging (TNM criteria), surgical procedures, radiation, and chemotherapy protocols.
- Univariate and multivariate analyses were performed to identify predictive factors for survival.
Main Results:
- Complete surgical resection with negative microscopic margins was achieved in 16 patients via total or partial cystectomy.
- Eleven patients (44%) achieved disease-free survival, with 10 followed for over 6 years.
- Surgical resection timing (pre- vs. post-chemotherapy/radiation) and salvage cystectomies were analyzed in relation to outcomes.
Conclusions:
- Complete surgical resection is a significant predictor of survival in bladder rhabdomyosarcoma.
- Achieving negative microscopic margins is critical for improving long-term outcomes.
- Multimodal therapy, including surgery, chemotherapy, and radiation, is vital for managing this rare pediatric cancer.